Abingworth Clinical Co-Development Fund 2 LP — Form D

Abingworth Clinical Co-Development Fund 2 LP of LONDON, X0, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-12-03. $207.5M was reported sold. Industry: Pooled Investment Fund.

Offering

• Filed: 2020-12-03
• Form: D
• Accession: 0001834445-20-000001
• Industry: Pooled Investment Fund
• Exemptions: 06b, 3C, 3C.7
• Amount sold: $207.5M
• Investors: 22
• Date of first sale: 2020-11-19
• Security types: fund interests
• Revenue range: Decline to Disclose
• SEC file number: 021-382087

Issuer

• Name: Abingworth Clinical Co-Development Fund 2 LP
• CIK: 0001834445
• Entity type: Limited Partnership
• Jurisdiction: UNITED KINGDOM
• Incorporated: 2020
• Address: 38 JERMYN STREET, LONDON, X0, SW1Y 6DN
• Phone: 44 0 20 7534 1508

Officers, directors & promoters (2)

More

• CIK 1834445 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search